首页> 美国卫生研究院文献>Cancers >Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value
【2h】

Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value

机译:实体癌中microRNA的变化及其预后价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) are evolutionarily conserved, naturally abundant, small, regulatory non-coding RNAs that inhibit gene expression at the post-transcriptional level in a sequence-specific manner. Each miRNA represses the protein expression of several coding genes in a manner proportional to the sequence complementarity with the target transcripts. MicroRNAs play key regulatory roles in organismal development and homeostasis. They control fundamental biological processes, such as stem-cell regulation and cellular metabolism, proliferation, differentiation, stress resistance, and apoptosis. Differential miRNA expression is found in malignant tumors in comparison to normal tissue counterparts. This indicates that miRNA deregulation contributes to the initiation and progression of cancer. Currently, miRNA expression signatures are being rigorously investigated in various tumor types, with the aim of developing novel, efficient biomarkers that can improve clinical management of cancer patients. This review discusses deregulated miRNAs in solid tumors, and focuses on their emerging prognostic potential.
机译:MicroRNA(miRNA)是进化保守的,天然丰富的,小的调节性非编码RNA,它们以序列特异性方式在转录后水平抑制基因表达。每个miRNA都以与靶转录本的序列互补性成比例的方式抑制多个编码基因的蛋白质表达。 MicroRNA在生物体发育和体内平衡中起着关键的调节作用。它们控制基本的生物学过程,例如干细胞调节和细胞代谢,增殖,分化,抗逆性和凋亡。与正常组织对应物相比,在恶性肿瘤中发现了不同的miRNA表达。这表明miRNA的失控有助于癌症的发生和发展。目前,在各种肿瘤类型中都对miRNA表达特征进行了严格的研究,目的是开发新颖,有效的生物标志物,以改善癌症患者的临床管理。这篇综述讨论了实体瘤中miRNA的失控,并着眼于其新兴的预后潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号